A BILL FOR AN ACT to amend the Indiana Code concerning human services.
Summary
HB 1087 would expand Indiana’s school-based access to opioid overdose reversal medication, such as naloxone. The bill authorizes the division of mental health and addiction, subject to available funding, to develop an application that would provide funds to a school corporation or a school maintained by a school corporation to obtain FDA-approved opioid overdose reversal medication. It also requires the state health commissioner to issue a statewide standing order, prescription, or protocol for such medication for each public school or school corporation.
The bill amends Indiana’s school emergency medication laws to specifically include FDA-approved opioid overdose reversal medication, including nasal spray, and requires at least two individual doses per school. It allows schools and school corporations to fill and store the medication under a prescription or statewide standing order, and permits cooperation with opioid overdose prevention organizations. The measure is set to take effect July 1, 2026.
Impact
HB 1087 would amend IC 12-21-5-10 and IC 20-34-4.5 to create a state-supported pathway for schools to obtain opioid overdose reversal medication and to require statewide standing orders for public schools and school corporations. In practical terms, it would place naloxone or similar FDA-approved products more directly into school emergency preparedness systems, while leaving implementation dependent in part on available funding and existing prescriber/pharmacy processes.
Sentiment
The bill’s overall direction appears strongly supportive of overdose prevention and school safety, with the text reflecting a public-health approach to ensuring rapid access to reversal medication in schools. No committee transcript or vote record was provided, so there is no documented floor or committee debate to indicate broader partisan or stakeholder sentiment. Based on the bill’s structure, the measure is framed as a preventive, nonpunitive response to the opioid crisis.
Contention
The main potential point of contention is the requirement that the state health commissioner issue a statewide standing order, prescription, or protocol for each public school or school corporation, which could raise questions about administrative burden, implementation logistics, and the scope of state mandates. Another possible issue is funding, since the grant/application program is expressly subject to available funding, meaning access may vary depending on appropriations. Stakeholders most likely to support the bill are public health advocates, school administrators seeking emergency preparedness tools, and opioid overdose prevention organizations; concerns would likely come from those wary of unfunded mandates or expanded state involvement in school medical protocols.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.